Ambu AS (OTCPK:AMBBY)
$ 15.65 0.2 (1.29%) Market Cap: 4.17 Bil Enterprise Value: 4.16 Bil PE Ratio: 124.21 PB Ratio: 5.05 GF Score: 97/100

Q4 2022 Ambu A/S Earnings Call Transcript

Nov 15, 2022 / 07:00AM GMT
Release Date Price: $11.5 (-14.75%)
Britt Meelby Jensen;S;CEO;Member of Management Board
Ambu A

/-&

So good morning, everyone. Very nice to have you on this call this morning for Ambu's Q4 and full year results as well as our strategy update. I'm Britt Meelby Jensen, the CEO of Ambu. And this morning, I'm here with Thomas Frederik Schmidt, our Chief Financial Officer; and Bassel Rifai, our Chief Marketing Officer.

So we will, in the agenda today, first go through our financial results and key events from the year that we have just closed. After that, we'll provide an update on our strategy, and we'll finish the call with a Q&A session.

So looking back at the past year, it has been an eventful year for Ambu. Our 2 main new products, cystoscope and our rhinolaryngoscope, have had a very good year selling over 700,000 scopes in the year.

Also, we have had 2 major launches towards the end of last fiscal year, the aScope 5 Bronchoscope and our gastroscope, which I'll come back and provide an update on later today.

Also during the year, we have expanded

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot